O'Byrne Jason

Track

Insider profile

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
O'Byrne Jason's trades of Vir Biotechnology Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-24
PlS Planned sale
43,488 +43.3%
138.65
US$269,658 		43,488 +43.3% 138.65 US$269,658
2026-02-24 2026-02-24
PrS Proposed sale
6,205
274.63
US$4,599,714 		6,205 274.63 US$4,599,714
2026-02-24 2026-02-23
PlS Planned sale
11,816 -24.4%
411.04
US$1,627,959 		11,816 -24.4% 411.04 US$1,627,959
2026-02-23 2026-02-23
PrS Proposed sale
2,089
7.45
US$15,569 		2,089 7.45 US$15,569
2025-11-18 2025-11-17
S Sale
6,799 -5.8%
5.56
US$37,782 		6,799 -5.8% 5.56 US$37,782
2025-11-17 2025-11-17
PrS Proposed sale
6,799
5.56
US$37,781 		6,799 5.56 US$37,781